Benzinga's Top Downgrades

Analysts at Credit Suisse downgraded Infinity Pharmaceuticals

from “outperform” to “neutral.” The target price for Infinity Pharmaceuticals is set to $20. Infinity's shares closed at $13.31 yesterday. Analysts at JMP Securities downgraded Progress Software

from “market outperform” to “market perform.” Progress Software's shares closed at $25.60 yesterday. RBC Capital downgraded Oracle

from “outperform” to “sector perform.” The target price for Oracle is set to $35. Oracle's shares closed at $34.56 yesterday. William Blair downgraded Brown & Brown

from “market perform” to “underperform.” Brown & Brown's shares closed at $30.26 yesterday.